Deitelzweig S - Search Results

1

Anticoagulant prophylaxis in medical patients: an objective assessment.

Deitelzweig S, Groce JB 3rd; Heparin Consensus Group. Deitelzweig S, et al. Pharmacotherapy. 2004 Aug;24(8 Pt 2):120S-126S. doi: 10.1592/phco.24.12.120s.36115. Pharmacotherapy. 2004. PMID: 15334857 Review.

2

Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney disease.

Ardeshirrouhanifard S, Ellenbogen MI, Segal JB, Streiff MB, Deitelzweig SB, Brotman DJ. Ardeshirrouhanifard S, et al. Among authors: deitelzweig sb. Thromb Res. 2023 Jan;221:45-50. doi: 10.1016/j.thromres.2022.11.020. Epub 2022 Nov 29. Thromb Res. 2023. PMID: 36470069

3

Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients.

Deitelzweig SB, Vanscoy GJ, Niccolai CS, Rihn TL. Deitelzweig SB, et al. Ann Pharmacother. 2003 Mar;37(3):402-11. doi: 10.1345/aph.1C152. Ann Pharmacother. 2003. PMID: 12639173 Review.

4

Medical management of venous thromboembolic disease.

Deitelzweig S, Jaff MR. Deitelzweig S, et al. Tech Vasc Interv Radiol. 2004 Jun;7(2):63-7. doi: 10.1053/j.tvir.2004.02.003. Tech Vasc Interv Radiol. 2004. PMID: 15252762 Review.

5

Prevention of venous thromboembolism in the orthopedic surgery patient.

Deitelzweig SB, McKean SC, Amin AN, Brotman DJ, Jaffer AK, Spyropoulos AC. Deitelzweig SB, et al. Cleve Clin J Med. 2008 Apr;75 Suppl 3:S27-36. doi: 10.3949/ccjm.75.suppl_3.s27. Cleve Clin J Med. 2008. PMID: 18494224 Free article. Review.

6

Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.

Deitelzweig SB, Becker R, Lin J, Benner J. Deitelzweig SB, et al. Thromb Haemost. 2008 Nov;100(5):810-20. Thromb Haemost. 2008. PMID: 18989525

7

Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?

Deitelzweig SB, Lin J, Hussein M, Battleman D. Deitelzweig SB, et al. J Thromb Thrombolysis. 2010 Jul;30(1):55-66. doi: 10.1007/s11239-009-0393-4. J Thromb Thrombolysis. 2010. PMID: 19795190

8

Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials.

Deitelzweig S, Amin A, Jing Y, Makenbaeva D, Wiederkehr D, Lin J, Graham J. Deitelzweig S, et al. J Med Econ. 2013 Sep;16(9):1163-8. doi: 10.3111/13696998.2013.826664. Epub 2013 Aug 8. J Med Econ. 2013. PMID: 23869941 Free article.

9

Budget impact analysis of betrixaban for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United Kingdom.

Guy H, Laskier V, Fisher M, Bucior I, Deitelzweig S, Cohen AT. Guy H, et al. Among authors: deitelzweig s. Expert Rev Pharmacoecon Outcomes Res. 2020 Jun;20(3):259-267. doi: 10.1080/14737167.2019.1629905. Epub 2019 Jun 19. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 31215264 Clinical Trial.

10

Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.

Barkoudah E, Piazza G, Hecht TEH, Grant P, Deitelzweig S, Fang MC, Fanikos J, Kao CK, Barnes GD, Chen T, Ramishvili T, Schnipper JL, Goldstein JN, Ruff CT, Kaatz S, Schwartz A, Connors JM, Goldhaber SZ. Barkoudah E, et al. Among authors: deitelzweig s. Am J Med. 2020 May;133 Suppl 1:1-27. doi: 10.1016/j.amjmed.2019.12.001. Am J Med. 2020. PMID: 32362349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page